FDA approves pasatru (garetosmab-grts) for FOP adults
Regeneron Pharmaceuticals (REGN) says the FDA approves pasatru (garetosmab-grts) for adults with fibrodysplasia ossificans progressiva.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.